908 Devices Inc. (MASS) Stock
908 Devices stock price chart
MASS stock quote & key statistics
908 Devices annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $56.2M | -$36.6M | -$0.39 |
| FY2024 | $59.6M | -$72.2M | -$1.23 |
| FY2023 | $50.2M | -$36.4M | -$1.13 |
| FY2022 | $46.9M | -$31.7M | -$1.07 |
| FY2021 | $42.2M | -$22.2M | -$0.80 |
Fiscal year ending December 31. Source: company filings via EODHD.
About 908 Devices Inc.
908 Devices Inc. is an innovative technology company at the forefront of commercial-stage advancements, specializing in purpose-built handheld and desktop mass spectrometry (Mass Spec) devices. These cutting-edge instruments are designed to analyze unknown and imperceptible materials across diverse sectors including life sciences research, bioprocessing, industrial biotech, forensics, and related fields. Central to its product portfolio are groundbreaking solutions like the MX908, a handheld Mass Spec device that offers rapid analysis capabilities for gas, liquid, and solid materials with unidentified compositions.
In addition to the MX908, 908 Devices features the Rebel, a compact desktop analyzer providing real-time insights into the extracellular environment during bioprocesses. This device enhances efficiency and precision in industrial applications. Furthermore, the company's ZipChip solution stands out as a plug-and-play platform for high-resolution sample separation, optimizing Mass Spec analysis by facilitating seamless integration into existing workflows.
Operating on a global scale, 908 Devices serves markets across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. Since its inception in 2012 and headquartered in Boston, Massachusetts, the company has cultivated a reputation for innovation and reliability in delivering transformative technology solutions. By continually pushing the boundaries of analytical capabilities, 908 Devices empowers industries worldwide to navigate complex challenges and unlock new insights through advanced Mass Spec technology.
With a commitment to advancing scientific discovery and industrial efficiency, 908 Devices remains dedicated to pioneering solutions that redefine how materials are analyzed and understood across diverse applications. By leveraging its expertise in Mass Spec innovation, the company continues to drive forward in creating tangible value for its global customer base.
908 Devices stock FAQ
What is the 908 Devices stock ticker symbol?
908 Devices Inc. trades on the NASDAQ under the ticker symbol MASS.
What sector and industry is 908 Devices in?
908 Devices Inc. is classified in the Healthcare sector, Medical Devices industry.
How many employees does 908 Devices have?
908 Devices Inc. has about 172 full-time employees.
What were 908 Devices's revenue and earnings last fiscal year?
908 Devices reported revenue of $56.2M and net income of -$36.6M in fiscal 2025, with earnings per share of -$0.39. Revenue declined 5.8% from the prior year.
Is 908 Devices in the Russell 2000?
Yes. 908 Devices Inc. (MASS) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did 908 Devices go public?
908 Devices stock began trading on December 18, 2020.
Russell 2000 Medical Devices stocks
All Russell 2000 →- AORTArtivion
- ATECAlphatec
- AXGNAxoGen
- BFLYButterfly Network
- CNMDCONMED
- ENOVEnovis
- ESTAEstablishment Labs
- GKOSGlaukos
- HAEHaemonetics
- IARTIntegra LifeSciences
- INSPInspire Medical Systems
- IRTCiRhythm
- ITGRInteger
- LIVNLivaNova
- NEOGNeogen
- NVCRNovoCure
- PRCTPROCEPT BioRobotics
- QDELQuidelOrtho
- SIBNSI-BONE
- TMDXTransMedics
- TNDMTandem Diabetes Care
- TXG10x Genomics
- UFPTUFP Technologies
- VREXVarex Imaging